Related Experiment Video
Updated: Feb 27, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
miR-205 Inhibits Neuroblastoma Growth by Targeting cAMP-Responsive Element-Binding Protein 1
Shu Chen1, Lianhua Jin2, Shu Nie2
1Department of Thoracic Surgery, The Second Hospital of Jilin UniversityChangchunP.R. China.
Abstract:
Accumulating evidence indicates that microRNA-205 (miR-205) is involved in tumor initiation, development, and metastasis in various cancers. However, its functions in neuroblastoma (NB) remain largely unclear. Here we found that miR-205 was significantly downregulated in human NB tissue samples and cell lines. miR-205 expression was lower in poorly differentiated NB tissues and those of advanced International Neuroblastoma Staging System stage. In addition, restoration of miR-205 in NB cells suppressed proliferation, migration, and invasion and induced cell apoptosis in vitro, as well as impaired tumor growth in vivo. cAMP-responsive element-binding protein 1 (CREB1) was identified as a direct target gene of miR-205. Expression of an miR-205 mimic in NB cells significantly diminished expression of CREB1 and the CREB1 targets BCL-2 and MMP9. CREB1 was also found to be upregulated in human NB tissues, its expression being inversely correlated with miR-205 expression (r = -0.554, p = 0.003). Importantly, CREB1 upregulation partially rescued the inhibitory effects of miR-205 on NB cells. These findings suggest that miR-205 may function as a tumor suppressor in NB by targeting CREB1.
Insights
MicroRNA-205 (miR-205) acts as a tumor suppressor in neuroblastoma (NB). Restoring miR-205 inhibits NB cell growth and metastasis by targeting cAMP-responsive element-binding protein 1 (CREB1).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA-205 (miR-205) is implicated in various cancers, but its role in neuroblastoma (NB) is not well understood.
- Neuroblastoma is a pediatric cancer with significant unmet needs in understanding its molecular drivers.
Purpose of the Study:
- To investigate the function of miR-205 in neuroblastoma.
- To identify the molecular targets of miR-205 in NB.
Main Methods:
- Quantitative real-time PCR to measure miR-205 and CREB1 expression in NB tissues and cell lines.
- In vitro assays (proliferation, migration, invasion, apoptosis) and in vivo tumor xenograft models to assess miR-205 function.
- Western blotting and luciferase reporter assays to validate CREB1 as a direct target of miR-205.
Main Results:
- miR-205 was significantly downregulated in NB tissues and cell lines, correlating with advanced stage and poor differentiation.
- Restoration of miR-205 suppressed NB cell proliferation, migration, invasion, and tumor growth, while inducing apoptosis.
- cAMP-responsive element-binding protein 1 (CREB1) was identified as a direct target of miR-205; CREB1 was upregulated in NB and inversely correlated with miR-205 levels. Upregulation of CREB1 partially rescued the tumor-suppressive effects of miR-205.
Conclusions:
- miR-205 functions as a tumor suppressor in neuroblastoma.
- The tumor-suppressive role of miR-205 in NB is mediated, at least in part, through the inhibition of its direct target, CREB1.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
MicroRNAs
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...

